Monika Holder, PA
Medical · Sarasota, FLNPI 1245524529
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 421 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,548 and has fallen 50.4% since, to $1,264 in 2025. Among medical clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 421 payments — averaging $24.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$2K
- AbbVie$1K
- Incyte Corporation$641
- Sanofi$587
- Johnson & Johnson$555
- Novartis$500
- plus $5K from 25 others
What the payments were for
- Food & beverage$9,93497%
- Education$2633%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 65 | $1,635 |
| AbbVie | 63 | $1,251 |
| Incyte Corporation | 19 | $641 |
| Sanofi | 19 | $587 |
| Johnson & Johnson | 25 | $555 |
| Novartis | 32 | $500 |
| Regeneron Healthcare Solutions, Inc. | 15 | $489 |
| Galderma Laboratories, L.p. | 16 | $438 |
| Dermavant Sciences, Inc. | 11 | $422 |
| Lilly USA, LLC | 15 | $408 |
| UCB, Inc. | 15 | $392 |
| E.r. Squibb & Sons, L.L.C. | 7 | $306 |
| Amgen | 12 | $298 |
| Mayne Pharma Commercial LLC | 11 | $274 |
| Journey Medical Corporation | 8 | $215 |
| Arcutis Biotherapeutics, Inc. | 14 | $208 |
| Botanix SB Inc | 9 | $203 |
| Pfizer | 10 | $188 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $181 |
| Boehringer Ingelheim | 7 | $177 |
| LEO Pharma Inc. | 3 | $145 |
| Almirall LLC | 6 | $135 |
| Organogenesis Inc. | 6 | $134 |
| Sebela Pharmaceuticals Inc. | 6 | $90 |
| EPI Health, LLC | 3 | $67 |
| Verrica Pharmaceuticals Inc. | 3 | $66 |
| Fresenius Kabi USA, LLC | 3 | $65 |
| Genentech USA, Inc. | 3 | $45 |
| Convatec Inc. | 2 | $38 |
| VYNE Pharmaceuticals Inc. | 2 | $34 |
| Biofrontera Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,198 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $44,873 |
| Fluocinonide | 64 | $1,803 |
| Fluorouracil | 24 | $1,611 |
| Betamethasone Dipropionate | 26 | $1,169 |
| Clindamycin Phosphate | 31 | $1,128 |
| Doxycycline Hyclate | 65 | $997 |
| ValacyclovirValacyclovir Hcl | 29 | $721 |
| Tretinoin | 14 | $638 |
| Clobetasol Propionate | 15 | $622 |
| Triamcinolone Acetonide | 63 | $548 |
| Ketoconazole | 51 | $487 |
| Nystatin | 45 | $427 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $416 |
| Mupirocin | 38 | $308 |
| Hydrocortisone | 17 | $156 |
Paid to pharmacies, not to this prescriber.
Other medical in Sarasota
- Matthew JohnsonSarasota$16K
- Jesse LebaronSarasota$16K
- Amy TraSarasota$16K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.